Cell Impact (FRA:ICL) Current Ratio: 3.06 (As of Mar. 2026) — 10% Below Median


What is Cell Impact Current Ratio?

Cell Impact FRA:ICL Current Ratio is 3.06 as of Mar. 2026, which is 10% below its 10-year median of 3.39. The stock has 7 warning signs investors should review. Among 3,073 Industrial Products companies, Cell Impact ranks better than 74.98% on this metric.

The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. Cell Impact's current ratio for the quarter that ended in Mar. 2026 was 3.06.

Cell Impact has a current ratio of 3.06. It indicates the company may not be efficiently using its current assets or its short-term financing facilities. This may also indicate problems in working capital management.

The historical rank and industry rank for Cell Impact's Current Ratio or its related term are showing as below:

FRA:ICL' s Current Ratio Range Over the Past 10 Years
Min: 0.42   Med: 3.39   Max: 7.93
Current: 3.06

During the past 13 years, Cell Impact's highest Current Ratio was 7.93. The lowest was 0.42. And the median was 3.39.

FRA:ICL's Current Ratio is ranked better than
74.98% of 3073 companies
in the Industrial Products industry
Industry Median: 1.96 vs FRA:ICL: 3.06

Cell Impact  (FRA:ICL) Current Ratio Explanation

The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.

Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.

The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.

If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.


Cell Impact Current Ratio Related Terms


Cell Impact Current Ratio Historical Data

* Premium members only.

The historical data trend for Cell Impact's Current Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cell Impact Current Ratio Chart

Cell Impact Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Current Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.60 5.43 3.58 3.03 2.02

Cell Impact Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Current Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.15 1.34 2.92 2.02 3.06

FRA:ICL vs CRS, ATI, MLI: Current Ratio Comparison

For the Metal Fabrication subindustry, Cell Impact's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cell Impact Current Ratio vs Industrial Products Industry

For the Industrial Products industry and Industrials sector, Cell Impact's Current Ratio distribution charts can be found below:

* The bar in red indicates where Cell Impact's Current Ratio falls into.



Cell Impact Current Ratio Calculation

The current ratio is mainly used to give an idea of the company's ability to pay back its short-term liabilities with its short-term assets.

Cell Impact's Current Ratio for the fiscal year that ended in Dec. 2025 is calculated as

Current Ratio (A: Dec. 2025 )=Total Current Assets (A: Dec. 2025 )/Total Current Liabilities (A: Dec. 2025 )
=6.567/3.25
=2.02

Cell Impact's Current Ratio for the quarter that ended in Mar. 2026 is calculated as

Current Ratio (Q: Mar. 2026 )=Total Current Assets (Q: Mar. 2026 )/Total Current Liabilities (Q: Mar. 2026 )
=5.796/1.896
=3.06

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Current Ratio →
What does a Current Ratio of 3.06 mean?
Cell Impact (FRA:ICL) has a Current Ratio of 3.06 as of Mar. 2026. This is 10% below median its historical median of 3.39. Over the past decade, Cell Impact's Current Ratio has ranged from 0.42 to 7.93. According to the industry distribution chart, Cell Impact ranks #769 out of 3073 companies in the Industrial Products industry, placing it in the top 25%.
Is Cell Impact's Current Ratio too high?
Cell Impact's current Current Ratio of 3.06 is 10% below median its 10-year median of 3.39. Over the past 10 years, this metric has ranged from a low of 0.42 to a high of 7.93. The Industrial Products industry median Current Ratio is 1.96. Cell Impact's value of 3.06 is 56.1% above this industry median. Based on the distribution chart, Cell Impact ranks #769 out of 3073 companies in the Industrial Products industry, which is in the top quartile — a strong position relative to peers.
How does Cell Impact's Current Ratio compare to CRS and ATI?
According to the Industrial Products industry distribution chart, Cell Impact ranks #769 out of 3073 companies for Current Ratio. This places Cell Impact in the top 25% of its industry — outperforming the majority of peers. The industry median Current Ratio is 1.96. Cell Impact's value of 3.06 is 56.1% above this benchmark. Historically, Cell Impact's own Current Ratio has ranged from 0.42 to 7.93 over the past decade. While the company's 10-year median is 3.39 vs. the industry median of 1.96, Cell Impact has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Ratio for an Industrial Products company?
The median Current Ratio among Industrial Products companies is 1.96, based on 3,073 companies in the industry. Companies in the top quartile (top 25%) have a Current Ratio significantly above this median, while those in the bottom quartile fall well below. However, Current Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Cell Impact's current Current Ratio of 3.06 is 56.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Ratio mean?
A high Current Ratio can signal that a stock is expensive relative to its fundamentals. For the Industrial Products industry, the median Current Ratio is 1.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cell Impact's current Current Ratio is 3.06, which is 10% below median its own 10-year median of 3.39. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cell Impact stock overvalued right now?
Based on GuruFocus' analysis, Cell Impact (FRA:ICL) is currently considered Fairly Valued. The stock's GF Value™ is €0.01, compared to a current price of €0.01 — trading right at its estimated fair value. The current Current Ratio is 3.06, which is 10% below median its 10-year median of 3.39 and 56.1% above the Industrial Products industry median of 1.96. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Ratio calculated?
Current Ratio is calculated from a company's financial statements. For Cell Impact (FRA:ICL), the current Current Ratio is 3.06 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cell Impact Business Description

Other Exchanges CI:Sweden
Address Kallmossvagen 7A, Karlskoga, SWE, 691 52
Cell Impact develops and manufactures flow plates for fuel cells and electrolyzers using materials such as graphite, stainless steel, and titanium. The company has developed and patented a high-velocity forming method, known as Cell Impact Forming, which enables the production of flow plates with advanced designs. Geographically, it operates in Sweden, Asia, the U.S., and Other Europe. It generates the majority of its revenue from Sweden.